Loper Bright and Preemption

Key Takeaways

• Supreme Court may redefine EPA preemption of state pesticide lawsuits
• Conservative justices are not uniformly backing broad preemption
• Loper Bright could restrict agency deference in statutory interpretation
• Decision could affect billions in potential liability for agro‑chemical companies
• Business community watches for clues on future Chevron deference

Pulse Analysis

The Monsanto v. Durnell case brings together two high‑stakes legal battles: massive product‑liability claims over Roundup and the broader question of federal preemption. Bayer argues that the EPA’s registration and labeling rules under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) should bar state‑law suits, a position that hinges on whether courts will treat agency regulations as the ultimate expression of federal law. The $1.25 million verdict, while modest compared with the billions Bayer has paid in settlements, serves as a test case for how aggressively the Supreme Court will protect federal regulatory schemes from state interference.

At the heart of the oral arguments is the 2024 Loper Bright decision, which emphasized the separation of powers by limiting the executive branch’s ability to declare what the law is without clear congressional delegation. Critics argue that Loper Bright undermines the Chevron deference framework that has long allowed agencies to interpret ambiguous statutes. If the Court extends Loper Bright to preemption contexts, agencies like the EPA may lose the latitude to preempt state tort claims unless Congress provides explicit language, reshaping the balance between regulatory flexibility and judicial oversight.

For the business community, the stakes extend far beyond pesticides. A ruling that narrows preemption could reopen a flood of state‑law challenges to products ranging from pharmaceuticals to consumer electronics, increasing compliance costs and litigation risk. Conversely, a decision that upholds broad preemption would reinforce the predictability that multinational firms rely on when navigating a patchwork of state regulations. Stakeholders are therefore watching the Court not just for the outcome of the Monsanto case, but for the broader signal it sends about the future of agency authority and the stability of the regulatory environment.